Cargando…
Large intestine-targeted nanoparticle-releasing oral vaccine to control genitorectal viral infection
Both rectal and vaginal mucosal surfaces serve as transmission routes for pathogenic microorganisms. Vaccination through large intestinal mucosa, previously proven protective for both mucosal sites in animal studies, can be achieved successfully by direct intra-colorectal (i.c.r.) administration, wh...
Autores principales: | Zhu, Qing, Talton, James, Zhang, Guofeng, Cunningham, Tshaka, Wang, Zijian, Waters, Robert C., Kirk, James, Eppler, Bärbel, Dennis M, Klinman, Sui, Yongjun, Gagnon, Susan, Belyakov, Igor M., Mumper, Russell J., Berzofsky, Jay A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475749/ https://www.ncbi.nlm.nih.gov/pubmed/22797811 http://dx.doi.org/10.1038/nm.2866 |
Ejemplares similares
-
P19-50 LB. Role of vaccine-induced innate and adaptive immunity in controlling mucosal transmission of SIV in macaques
por: Sui, Y, et al.
Publicado: (2009) -
Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy
por: Chanzu, Nadia, et al.
Publicado: (2014) -
Myeloid Cell-Mediated Trained Innate Immunity in Mucosal AIDS Vaccine Development
por: Sui, Yongjun, et al.
Publicado: (2020) -
Potential SARS-CoV-2 Immune Correlates of Protection in Infection and Vaccine Immunization
por: Sui, Yongjun, et al.
Publicado: (2021) -
IL-7 in SARS-CoV-2 Infection and as a Potential Vaccine Adjuvant
por: Bekele, Yonas, et al.
Publicado: (2021)